Capricor Therapeutics (CAPR) Leases (2021 - 2025)
Historic Leases for Capricor Therapeutics (CAPR) over the last 6 years, with Q3 2025 value amounting to $13.9 million.
- Capricor Therapeutics' Leases rose 82864.73% to $13.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.9 million, marking a year-over-year increase of 82864.73%. This contributed to the annual value of $1.3 million for FY2024, which is 3597.58% down from last year.
- As of Q3 2025, Capricor Therapeutics' Leases stood at $13.9 million, which was up 82864.73% from $939204.0 recorded in Q2 2025.
- In the past 5 years, Capricor Therapeutics' Leases ranged from a high of $13.9 million in Q3 2025 and a low of $939204.0 during Q2 2025
- Moreover, its 5-year median value for Leases was $2.1 million (2023), whereas its average is $2.7 million.
- Data for Capricor Therapeutics' Leases shows a peak YoY increase of 82864.73% (in 2025) and a maximum YoY decrease of 4475.27% (in 2025) over the last 5 years.
- Capricor Therapeutics' Leases (Quarter) stood at $2.8 million in 2021, then fell by 16.72% to $2.3 million in 2022, then fell by 12.76% to $2.1 million in 2023, then crashed by 35.98% to $1.3 million in 2024, then soared by 961.29% to $13.9 million in 2025.
- Its Leases stands at $13.9 million for Q3 2025, versus $939204.0 for Q2 2025 and $1.1 million for Q1 2025.